News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
679,772 Results
Type
Article (38826)
Company Profile (248)
Press Release (640698)
Section
Business (203596)
Career Advice (1979)
Deals (35353)
Drug Delivery (79)
Drug Development (80663)
Employer Resources (167)
FDA (16035)
Job Trends (14782)
News (343876)
Policy (32422)
Tag
Academia (2529)
Africa (712)
Alliances (48984)
Alzheimer's disease (1153)
Approvals (15968)
Arizona (174)
Artificial intelligence (76)
Asia (36839)
Australia (5994)
Bankruptcy (350)
Best Places to Work (11326)
Biosimilars (65)
Biotechnology (178)
C2C Services and Suppliers (78793)
California (2005)
Canada (976)
Cancer (552)
Career advice (1649)
Cell therapy (133)
China (159)
Clinical research (63357)
Collaboration (170)
Colorado (83)
Compensation (89)
Connecticut (80)
COVID-19 (2493)
Cystic fibrosis (78)
Data (423)
Diabetes (90)
Diagnostics (5989)
Drug pricing (70)
Earnings (83689)
Employer resources (142)
Europe (78754)
Events (107957)
Executive appointments (166)
FDA (16309)
Florida (289)
Funding (170)
Gene therapy (99)
GLP-1 (518)
Government (4301)
Healthcare (18621)
Hotbed/Location (480975)
Illinois (267)
Indiana (151)
Infectious disease (2528)
Inflammatory bowel disease (93)
Interviews (306)
IPO (16208)
Job creations (3618)
Job search strategy (1413)
Kansas (94)
Layoffs (396)
Legal (7835)
Lung cancer (118)
Manufacturing (98)
Maryland (419)
Massachusetts (1619)
Medical device (13076)
Medtech (13081)
Mergers & acquisitions (19033)
Metabolic disorders (267)
Michigan (126)
Minnesota (218)
Neuroscience (1323)
New Jersey (616)
New York (630)
NextGen Class of 2024 (6482)
Non-profit (4457)
North Carolina (597)
Northern California (878)
Obesity (162)
Ohio (111)
Opinion (172)
Patents (77)
Pennsylvania (605)
People (55891)
Phase I (19623)
Phase II (27897)
Phase III (20857)
Pipeline (122)
Postmarket research (2549)
Preclinical (8330)
Press Release (64)
Radiopharmaceuticals (230)
Rare diseases (148)
Real estate (5883)
Recruiting (63)
Regulatory (21265)
Research institute (2304)
Resumes & cover letters (347)
South America (1085)
Southern California (815)
Startups (3560)
Texas (257)
United States (9002)
Vaccines (486)
Washington State (257)
Weight loss (135)
Date
Today (90)
Last 7 days (565)
Last 30 days (2527)
Last 365 days (36835)
2024 (26837)
2023 (40076)
2022 (51178)
2021 (55715)
2020 (54091)
2019 (46547)
2018 (35030)
2017 (32113)
2016 (31483)
2015 (37553)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29264)
2010 (27328)
679,772 Results for "resmed inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
ResMed Inc. announced results for its quarter ended March 31, 2024.
April 25, 2024
·
19 min read
Business
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
ResMed Inc. announced results for its quarter ended December 31, 2023.
January 24, 2024
·
20 min read
Business
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
August 1, 2024
·
19 min read
Business
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended September 30, 2023.
October 26, 2023
·
16 min read
Business
ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 28, 2024
·
1 min read
Business
ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
September 11, 2024
·
1 min read
Biotech Beach
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
ResMed announced the U.S. launch of the AirFit F40, an ultra-compact, full-face mask offering the comfort of smaller masks without sacrificing performance in order to help improve sleep apnea therapy compliance.
March 6, 2024
·
3 min read
Business
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023
ResMed Inc. announced results for its quarter ended June 30, 2023.
August 3, 2023
·
20 min read
Biotech Beach
ResMed’s 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
ResMed, the global leader in digital health and cloud-connected medical devices that transform care for people with sleep apnea, COPD, and other chronic diseases, announced the results of its 2024 Global Sleep Survey in conjunction with World Sleep Day, shedding light on the critical sleep challenges faced by people around the world.
March 15, 2024
·
4 min read
Press Releases
ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
August 16, 2024
·
2 min read
1 of 67,978
Next
